We are live on ! Find out more
CALC icon

CalciMedica
CALC

27 hedge funds and large institutions have $5.97M invested in CalciMedica in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,400% more call options, than puts

Call options by funds: $75K | Put options by funds: $3K

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

8% more funds holding

Funds holding: 25 → 27 (+2)

5% less capital invested

Capital invested by funds: $6.27M → $5.97M (-$292K)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
8
Closed
3
Calls
$75K
Puts
$3K
Net Calls
+$72K
Net Calls Change
-$70K

Top Buyers

1
Belvedere Trading
Belvedere Trading
Illinois
+$4.25K
2
UBS Group
UBS Group
Switzerland
+$4.14K
3
Morgan Stanley
Morgan Stanley
New York
+$1.12K
4
NA
NewEdge Advisors
Louisiana
+$796
5
ASN
Advisory Services Network
Georgia
+$505

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$35.6K
2
BCM
Bridgeway Capital Management
Texas
-$17.7K
3
First Manhattan
First Manhattan
New York
-$16.6K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$14.7K
5
Jane Street
Jane Street
New York
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$2.64M – – –
O
2
OrbiMed
New York
$2.08M – – –
BCM
3
BML Capital Management
Indiana
$618K +$990K +88,282 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$210K +$146 +13 +0%
First Manhattan
5
First Manhattan
New York
$136K -$16.6K -1,476 -7%
Renaissance Technologies
6
Renaissance Technologies
New York
$78K -$35.6K -3,178 -22%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$50.1K -$606 -54 -0.7%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$33K -$135 -12 -0.3%
JJ
9
Johnson & Johnson
New Jersey
$25K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$22.4K -$14.7K -1,313 -29%
BCM
11
Bridgeway Capital Management
Texas
$20.9K -$17.7K -1,578 -35%
State Street
12
State Street
Massachusetts
$17.5K – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$10K – – –
Northern Trust
14
Northern Trust
Illinois
$8.05K – – –
Morgan Stanley
15
Morgan Stanley
New York
$6.71K +$1.12K +100 +12%
Brown Advisory
16
Brown Advisory
Maryland
$5.43K -$5.99K -534 -41%
PNC Financial Services Group
17
PNC Financial Services Group
Pennsylvania
$4.31K – – –
UBS Group
18
UBS Group
Switzerland
$2.69K +$4.14K +369 +2,460%
Belvedere Trading
19
Belvedere Trading
Illinois
$2.65K +$4.25K +379 New
Federated Hermes
20
Federated Hermes
Pennsylvania
$1.19K – – –
BlackRock
21
BlackRock
New York
$321 – – –
ASN
22
Advisory Services Network
Georgia
$316 +$505 +45 New
Wells Fargo
23
Wells Fargo
California
$54 +$11 +1 +14%
Bank of America
24
Bank of America
North Carolina
$22 +$34 +3 New
NA
25
NewEdge Advisors
Louisiana
$1 +$796 +71 New
1
2

CALC Hedge Fund Activity: Q4 2022 in Review

27 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2022, worth a combined $5.97M — down 4.7% from $6.27M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CALC positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 8 trimmed.

The largest buyer was Belvedere Trading, opening a new position worth an estimated $4.25K. The largest seller was Renaissance Technologies, cutting an estimated $35.6K.

  • 27 institutional investors held CalciMedica (CALC) as of Q4 2022, up from 25 in Q3 2022.
  • Funds reported $5.97M of CalciMedica stock for Q4 2022, down 4.7% quarter-over-quarter.
  • 5 funds opened new CalciMedica positions in Q4 2022 and 3 closed out, a net change of +2 holders.
  • The largest CalciMedica buyer in Q4 2022 was Belvedere Trading, an estimated $4.25K added.
  • The largest CalciMedica seller in Q4 2022 was Renaissance Technologies, an estimated $35.6K sold.

Based on aggregated 13F filings for Q4 2022.